Presented Monday at the annual meeting of the American Society of Clinical Oncology, the cure for liver cancer in Sorafenib.
Phase III clinical trial data of this miracle pill revealed that chances of survival from final stage liver cancer is increased by 44% or about three months life extension.
Final stage liver cancer is deadly and currently patients suffering this condition have no treatment option.
Sorafenib is a pill that directly targets malignant cancer cells and cuts off the blood supply feeding the tumour and has been found in a large scale multinational trial, conducted by researchers from the Mount Sinai School of …read more